A trial study of RhinoSleep for the diagnosis of sleep apnea
Related Experiment Video
Updated: Oct 6, 2026
Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
S Miyazaki1, T Tanaka, Y Itasaka
1Department of Otolaryngology, Akita University School of Medicine, Akita, Japan. soichiro@med.akita-u.ac.jp
Abstract:
RhinoSleep was developed to diagnose obstructive sleep apnea (OSA). The RhinoSleep consists of a soft catheter, a measuring probe, and a computer. The soft catheter is inserted through the naris into the esophagus. The catheter is connected to the measuring probe, which creates and sends a continuous noise signal into the catheter. When the catheter is compressed during an obstruction, the sound reflections change, making it possible to identify both the level and the duration of the obstruction. Sixteen OSA patients were examined using RhinoSleep and daytime polysomnography simultaneously. With RhinoSleep, we successfully examined 13 cases. This trial study identified problems with RhinoSleep, such as vomiting of the catheter, hardware instability, and the criteria decision for the analysis of OSA.
